Long-Term Survival after Reconstructive Operation in Patients with Arteriosclerosis Obliterans

Author:

Ota Toshiaki1,Okada Masayoshi1,Yoshida Masato1,Tsukube Takuro1,Matsuda Hitoshi1

Affiliation:

1. Department of Surgery, Division , Kobe University School of Medicine, Kobe, Japan

Abstract

Postoperative long-term survival for arteriosclerosis obliterans (ASO) of lower extremities was examined in 218 patients who underwent reconstructive surgery from 1973 to 1992. The causes of late deaths and their relation to the arteriosclerosis of various organs were also examined. Patients were divided into three groups according to the type of operation: aortoiliac/femoral (AIF), axillo/femorofemoral (AxF), and femoropopliteal bypass (FP) and were then divided into two subgroups according to the times of operation: "former decade" (subgroup F, 1973-1982, AIF 43, AxF 31, FP 10) and "latter decade" (subgroup L, 1983-1992, AIF 58, AxF 40, FP 36). The mean ages at operation for AIF-F/L were sixty/sixty-three years, and these were significantly younger than sixty-nine/seventy for AxF-F/L and sixty-five/sixty-seven for FP-F/L. There were 74 late-death patients, and of them, 57 (77%) died of arteriosclerosis-related diseases of various organs such as ischemic heart disease. Among these 57 patients, 39 (68%) experienced organ failure as a preop erative complication, whereas in the remaining 18, such failure was not clinically evident prior to operation. The survival rates at five/ten years after operation were 84%/61% in AIF-F, 88%/76% in AIF-L, 49%/20% in AXF-F, 75%/52% in AXF-L, and 73%/73% in FRL. The survival rate at ten years for subgroup L was 66% and was higher as compared with 42% for subgroup F owing in large part to the significant improvement in AXE In conclusion, for patients with ASO, postoperative life expectancy improved recently, but arteriosclerosis of various organs was still the main cause of late deaths. Lifelong critical care for systemic organs was necessary even in patients in whom such lesions were not yet clinically evident at the time of operation.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3